Evidence map›Paper›PMID 36982564›Full record

ArticleInternational journal of molecular sciences2023

Characterization and Proteomic Analysis of Plasma EVs Recovered from Healthy and Diseased Dogs with Canine Leishmaniosis.

Sofia Esteves, Clara Lima, Inês Costa, Hugo Osório, Carmen Fernandez-Becerra, Nuno Santarém, Anabela Cordeiro-da-Silva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Protein dysregulation duringFrontiers in immunology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sofia EstevesInstituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Clara LimaInstituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-2490-1570
Inês CostaInstituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-6299-8417
Hugo OsórioInstituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-6362-8255
Carmen Fernandez-BecerraISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 149-153, CEK Building, 08036 Barcelona, Spain.ORCID 0000-0001-5154-0013
Nuno SantarémInstituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Anabela Cordeiro-da-SilvaInstituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0003-2392-6087
Universidade do Porto · PTInstituto de Salud Carlos III · ES

Funding

Fundação para a Ciência e Tecnologia PTDC/CVT-CVT/6798/2020Fundació La Marató de TV3 566/U/2018Ministerio de Ciencia e Innovación PID2019-111795RB-I00Portuguese Mass Spectrometry Network LISBOA-01-0145-FEDER-022125Spanish Ministry of Science and Innovation CEX2018- 000806-S
6 · The paper itself

Abstract

Dogs are highly valued companions and work animals that are susceptible to many life-threatening conditions such as canine leishmaniosis (CanL). Plasma-derived extracellular vesicles (EVs), exploited extensively in biomarker discovery, constitute a mostly untapped resource in veterinary sciences. Thus, the definition of proteins associated with plasma EVs recovered from healthy and diseased dogs with a relevant pathogen would be important for biomarker development. For this, we recovered, using size-exclusion chromatography (SEC), EVs from 19 healthy and 20 CanL dogs' plasma and performed proteomic analysis by LC-MS/MS to define their core proteomic composition and search for CanL-associated alterations. EVs-specific markers were identified in all preparations and also non-EVs proteins. Some EVs markers such as CD82 were specific to the healthy animals, while others, such as the Integrin beta 3 were identified in most samples. The EVs-enriched preparations allowed the identification of 529 canine proteins that were identified in both groups, while 465 and 154 were only identified in healthy or CanL samples, respectively. A GO enrichment analysis revealed few CanL-specific terms.

Indexed as

Dog DiseasesLeishmania infantumLeishmaniasisLeishmaniasis, VisceralAnimalsBiomarkersChromatography, LiquidDogsProteomicsTandem Mass SpectrometryBiomarkerscanine leishmaniosisdogsexosomesextracellular vesiclesLeishmaniaLeishmania infantumleishmaniasisparasitesproteomics

Identifiers

PMID36982564
PMCPMC10056832
OpenAlexW4324150177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.